The effects of Src inhibition suggest that the Erb2 and B-Raf/MEK/ERK pathways are involved in Src mediated signaling in ARPKD and that this occurs without any reduction in cAMP levels. The gene discussed is SRC; the disease is autosomal recessive polycystic kidney disease.